Related Experiment Videos

Phenotypic analysis of cerebrospinal fluid cells over the course of Lyme meningoradiculitis

E Sindern1, J P Malin

  • 1Department of Neurology, Ruhr University, Kliniken Bergmannsheil, Bochum, Germany.

Acta Cytologica
|January 1, 1995
PubMed

Insights

Cerebrospinal fluid analysis for Lyme meningoradiculitis shows T lymphocytes, plasma cells, and B cells. Cell counts normalize post-treatment, but B cells may persist, and the CD4/CD8 ratio may indicate disease activity.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Lyme meningoradiculitis is a neurological manifestation of Lyme disease.
  • Cerebrospinal fluid (CSF) analysis is crucial for diagnosing central nervous system involvement.
  • Specific cytologic abnormalities in CSF can aid in diagnosis and monitoring.

Purpose of the Study:

  • To characterize cytologic abnormalities in CSF of patients with Lyme meningoradiculitis.
  • To evaluate changes in CSF cell counts and subsets during and after antibiotic treatment.
  • To identify potential CSF markers for disease activity and persistence.

Main Methods:

  • CSF samples were analyzed cytologically.
  • Cell counts, differential counts (T lymphocytes, B cells), and CD4/CD8 ratios were assessed.
  • Repeat examinations were performed 100-130 days after disease onset.
  • Patients received antibiotic treatment.

Main Results:

  • Pronounced mononuclear pleocytosis with T lymphocytes, plasma cells, and IgM-positive B cells was observed.
  • CSF cell counts decreased significantly, nearing normal levels 100-130 days post-onset.
  • B cells persisted in most patients throughout the observation period.
  • A decline in the CD4/CD8 ratio was noted in all patients after antibiotic treatment.

Conclusions:

  • CSF cytology reveals distinct abnormalities in Lyme meningoradiculitis, including specific lymphocyte and plasma cell populations.
  • While cell counts normalize, persistent B cells may not correlate with ongoing CNS inflammation.
  • The CD4/CD8 ratio may serve as a valuable marker for assessing Lyme meningoradiculitis activity post-treatment.

Related Concept Videos